Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a BRCA2 Reversion Mutation

被引：7

作者：

Grossman, Joseph E. ^{[1
]}

Wu, Yubo ^{[1
]}

Ye, Huihui ^{[1
]}

Bhatt, Rupal S. ^{[1
]}

机构：

[1] Harvard Med Sch, Boston, MA 02115 USA

来源：

JCO PRECISION ONCOLOGY | 2018年 / 2卷

基金：

美国国家卫生研究院;

关键词：

EXPRESSION;

D O I：

10.1200/PO.18.00193

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1 / 5

页数：5

共 14 条

[1] Basal cell carcinoma of the prostate: A clinicopathologic study of 29 cases [J].

Ali, Tehmina Z. ;

Epstein, Jonathan I. .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (05) :697-705

[2]

[Anonymous], J CLIN ONCOL S

[3] Somatic Reversion of Germline BRCA2 Mutation Confers Resistance to Poly(ADP-ribose) Polymerase Inhibitor Therapy [J].

Banda, Kalyan ;

Swisher, Elizabeth M. ;

Wu, David ;

Pritchard, Colin C. ;

Gadi, V. K. .

JCO PRECISION ONCOLOGY, 2018, 2 :1-6

[4]

Begnami MD, 2007, ARCH PATHOL LAB MED, V131, P637

[5] Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature [J].

Chang, Kun ;

Dai, Bo ;

Kong, YunYi ;

Qu, YuanYuan ;

Wu, JianNong ;

Ye, DingWei ;

Yao, XuDong ;

Zhang, ShiLin ;

Zhang, HaiLiang ;

Zhu, Yao ;

Yao, WeiQiang .

WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11 :1-6

[6] Clinically significant long-term maintenance treatment with olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). [J].

Gourley, Charlie ;

Friedlander, Michael ;

Matulonis, Ursula A. ;

Shirinkin, Vadim ;

Selle, Frederic ;

Scott, Clare L. ;

Safra, Tamar ;

Fielding, Anitra ;

Rowe, Philip ;

Ledermann, Jonathan A. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[7] PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression [J].

Jiao, Shiping ;

Xia, Weiya ;

Yamaguchi, Hirohito ;

Wei, Yongkun ;

Chen, Mei-Kuang ;

Hsu, Jung-Mao ;

Hsu, Jennifer L. ;

Yu, Wen-Hsuan ;

Du, Yi ;

Lee, Heng-Huan ;

Li, Chia-Wei ;

Chou, Chao-Kai ;

Lim, Seung-Oe ;

Chang, Shih-Shin ;

Litton, Jennifer ;

Arun, Banu ;

Hortobagyi, Gabriel N. ;

Hung, Mien-Chie .

CLINICAL CANCER RESEARCH, 2017, 23 (14) :3711-3720

[8] Combination of PDL-1 and PARP inhibition in an unselected population with metastatic castrate-resistant prostate cancer (mCRPC). [J].

Karzai, Fatima ;

Madan, Ravi Amrit ;

Owens, Helen ;

Hankin, Amy ;

Couvillon, Anna ;

Cordes, Lisa M. ;

Fakhrejahani, Farhad ;

Houston, Nicole D. ;

Trepel, Jane B. ;

Chen, Clara ;

Edelman, Daniel C. ;

Meltzer, Paul S. ;

Steinberg, Seth M. ;

Gulley, James L. ;

Dahut, William L. ;

Lee, Jung-min .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[9] DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer [J].

Mateo, J. ;

Carreira, S. ;

Sandhu, S. ;

Miranda, S. ;

Mossop, H. ;

Perez-Lopez, R. ;

Rodrigues, D. Nava ;

Robinson, D. ;

Omlin, A. ;

Tunariu, N. ;

Boysen, G. ;

Porta, N. ;

Flohr, P. ;

Gillman, A. ;

Figueiredo, I. ;

Paulding, C. ;

Seed, G. ;

Jain, S. ;

Ralph, C. ;

Protheroe, A. ;

Hussain, S. ;

Jones, R. ;

Elliott, T. ;

McGovern, U. ;

Bianchini, D. ;

Goodall, J. ;

Zafeiriou, Z. ;

Williamson, C. T. ;

Ferraldeschi, R. ;

Riisnaes, R. ;

Ebbs, B. ;

Fowler, G. ;

Roda, D. ;

Yuan, W. ;

Wu, Y. -M. ;

Cao, X. ;

Brough, R. ;

Pemberton, H. ;

A'Hern, R. ;

Swain, A. ;

Kunju, L. P. ;

Eeles, R. ;

Attard, G. ;

Lord, C. J. ;

Ashworth, A. ;

Rubin, M. A. ;

Knudsen, K. E. ;

Feng, F. Y. ;

Chinnaiyan, A. M. ;

Hall, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18) :1697-1708

[10] Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer [J].

Neuhausen, S ;

Gilewski, T ;

Norton, L ;

Tran, T ;

McGuire, P ;

Swensen, J ;

Hampel, H ;

Borgen, P ;

Brown, K ;

Skolnick, M ;

ShattuckEidens, D ;

Jhanwar, S ;

Goldgar, D ;

Offit, K .

NATURE GENETICS, 1996, 13 (01) :126-128

← 1 2 →